# AP1G2

## Overview
AP1G2, or adaptor related protein complex 1 subunit gamma 2, is a gene that encodes a protein involved in the adaptor protein complex 1 (AP-1), which is essential for the formation of clathrin-coated vesicles. The AP1G2 protein is characterized by the presence of a gamma-adaptin ear domain, which facilitates interactions with various accessory proteins, thereby playing a critical role in vesicle formation and trafficking within the cell. This protein is categorized as a clathrin adaptor protein, which is integral to the processes of endocytosis and intracellular transport. AP1G2 is subject to post-translational modifications, such as phosphorylation, which regulate its function and interactions. Additionally, the gene produces splice variant isoforms, contributing to the functional diversity of the protein and its involvement in a range of cellular activities (Zhou2022AP1G2).

## Structure
AP1G2, or adaptor related protein complex 1 subunit gamma 2, is a component of the adaptor protein complex 1 (AP-1), which plays a crucial role in the formation of clathrin-coated vesicles. The protein structure of AP1G2 includes the gamma-adaptin ear domain, which is essential for interactions with accessory proteins. This domain is a significant feature of the protein, contributing to its ability to mediate various protein-protein interactions necessary for vesicle formation and trafficking.

The protein may undergo post-translational modifications, such as phosphorylation, which can regulate its function and potentially influence its interaction with other proteins. These modifications are critical for the dynamic regulation of AP1G2's role in cellular processes.

AP1G2 is also known to have splice variant isoforms, which may contribute to its functional diversity. These isoforms can result in variations in the protein's structure and function, allowing it to participate in a broader range of cellular activities. The presence of these isoforms highlights the complexity and adaptability of AP1G2 in fulfilling its roles within the cell.

## Clinical Significance
The AP1G2 gene has been implicated in several clinical conditions due to its role in cellular trafficking and protein sorting. In myelodysplasia (MDS), mutations in spliceosome components such as SF3B1, U2AF1, and SRSF2 lead to aberrant splicing events involving AP1G2. These events are associated with clinical variables like absolute neutrophil count (ANC), suggesting a link between increased aberrant splicing and higher ANC in MDS cases (Pellagatti2018Impact).

In the context of autism spectrum disorders (ASDs), a variant in the AP1G2 gene has been identified with an odds ratio of 1.67, indicating a potential association with autism. This variant was found in high-risk autism families and suggests a possible role for AP1G2 in the disorder (Matsunami2014Identification).

Although AP1G2 was examined in a genome-wide association study for sudden cardiac arrest (SCA) in patients with coronary artery disease, no specific diseases or conditions were directly associated with AP1G2 mutations in this context. However, the gene is involved in receptor-mediated endocytosis, which may have implications for its role in disease (Aouizerat2011GWAS).

## Interactions
The AP1G2 protein in Arabidopsis is involved in several interactions with other proteins, particularly those related to clathrin-mediated endocytosis. AP1G2 interacts directly with members of the PICALM subfamily, specifically PICALM5A, PICALM5B, PICALM9A, and PICALM9B. These proteins are clathrin adaptor proteins involved in the formation of clathrin-coated vesicles. The interactions between AP1G2 and these PICALM proteins have been confirmed through yeast two-hybrid assays and bimolecular fluorescence complementation analysis, demonstrating co-localization on the membrane and suggesting a role in gametophyte development (Zhou2022AP1G2).

AP1G2 is part of a heterotetrameric protein complex that is crucial for sorting proteins at the trans-Golgi network and endosomes. This complex is involved in broader cellular processes, including vesicular transport and potentially regulating the expression of other proteins during the development stages of ovules (Zhou2022AP1G2). The interactions of AP1G2 with PICALM proteins are associated with the regulation of Ca2+ signaling, which is important for gametogenesis (Zhou2022AP1G2).


## References


[1. (Zhou2022AP1G2) Yongmei Zhou, Wenqin Fang, Ziqin Pang, Li-Yu Chen, Hanyang Cai, Noor-Ul- Ain, Men-Chi Chang, and Ray Ming. Ap1g2 affects mitotic cycles of female and male gametophytes in arabidopsis. Frontiers in Plant Science, July 2022. URL: http://dx.doi.org/10.3389/fpls.2022.924417, doi:10.3389/fpls.2022.924417. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fpls.2022.924417)

[2. (Matsunami2014Identification) Nori Matsunami, Charles H Hensel, Lisa Baird, Jeff Stevens, Brith Otterud, Tami Leppert, Tena Varvil, Dexter Hadley, Joseph T Glessner, Renata Pellegrino, Cecilia Kim, Kelly Thomas, Fengxiang Wang, Frederick G Otieno, Karen Ho, Gerald B Christensen, Dongying Li, Rytis Prekeris, Christophe G Lambert, Hakon Hakonarson, and Mark F Leppert. Identification of rare dna sequence variants in high-risk autism families and their prevalence in a large case/control population. Molecular Autism, January 2014. URL: http://dx.doi.org/10.1186/2040-2392-5-5, doi:10.1186/2040-2392-5-5. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/2040-2392-5-5)

[3. (Aouizerat2011GWAS) Bradley E Aouizerat, Eric Vittinghoff, Stacy L Musone, Ludmila Pawlikowska, Pui-Yan Kwok, Jeffrey E Olgin, and Zian H Tseng. Gwas for discovery and replication of genetic loci associated with sudden cardiac arrest in patients with coronary artery disease. BMC Cardiovascular Disorders, June 2011. URL: http://dx.doi.org/10.1186/1471-2261-11-29, doi:10.1186/1471-2261-11-29. This article has 51 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2261-11-29)

[4. (Pellagatti2018Impact) Andrea Pellagatti, Richard N. Armstrong, Violetta Steeples, Eshita Sharma, Emmanouela Repapi, Shalini Singh, Andrea Sanchi, Aleksandar Radujkovic, Patrick Horn, Hamid Dolatshad, Swagata Roy, John Broxholme, Helen Lockstone, Stephen Taylor, Aristoteles Giagounidis, Paresh Vyas, Anna Schuh, Angela Hamblin, Elli Papaemmanuil, Sally Killick, Luca Malcovati, Marco L. Hennrich, Anne-Claude Gavin, Anthony D. Ho, Thomas Luft, Eva Hellström-Lindberg, Mario Cazzola, Christopher W. J. Smith, Stephen Smith, and Jacqueline Boultwood. Impact of spliceosome mutations on rna splicing in myelodysplasia: dysregulated genes/pathways and clinical associations. Blood, 132(12):1225–1240, September 2018. URL: http://dx.doi.org/10.1182/blood-2018-04-843771, doi:10.1182/blood-2018-04-843771. This article has 207 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2018-04-843771)